Can we eat to starve cancer?
Please see a video of Dr. William Li talk about the anti-angiogenesis protocol. It’s all about eating certain foods which prevent cancer from forming blood vessels, thus preventing an existing cancer from spreading throughout the body. Dr. Li says a cancer is not life threatening as long as it does not form blood vessels.
Short video but very profound.
Why you should listen to him:
Many of society’s most devastating diseases — cancer, cardiovascular disease, diabetes and Alzheimer’s, to name a few — share a common denominator: faulty angiogenesis, the body’s growth of new capillary blood vessels. Given excessive or insufficient blood vessel growth, serious health issues arise. While researching under Harvard surgeon Judah Folkman, who pioneered the study of angiogenesis, Li learned how angiogenesis-based medicine helps patients overcome numerous diseases by restoring the balance of blood-vessel growth.
Li co-founded the Angiogenesis Foundation in 1994. The foundation’s Project ENABLE — a global system that integrates patients, medical experts and healthcare professionals — democratizes the spread and implementation of knowledge about angiogenesis-based medicines, diet and lifestyle. Some 40,000 physicians have been educated on new treatments, ranging from cancer care to wound care, by the foundation’s faculty of medical experts, and they are bringing new, lifesaving and disease-preventing techniques to people around the world.
Published articles:Antiangiogenesis in haematological malignancies. British Journal of Haematology 2008;143:622-631. Read this article. Antiangiogenesis in the treatment of skin cancer. Journal of Drugs and Dermatology 2008; 7(1Suppl1):s17-24. Read this article. The role of therapeutic angiogenesis in tissue repair and regeneration. Advances in Skin & Wound Care 2005;18(9):491-500. Read this article. Imiquimod as an antiangiogenic agent. Journal of Drugs in Dermatology 2005;4(6):708-17. Read this article. Multiple roles of cyclooxygenase-2 in tumor angiogenesis: a target for antiangiogenic therapy. Seminars in Oncology 2004; 31(2) Suppl7:2-11. Read this article. Alzheimer’s disease and angiogenesis. The Lancet 2003; 361:605-607. Read this article. Tumor angiogenesis: molecular pathology, therapeutic targeting and imaging. Academic Radiology 2000; 7(10): 800-811. Read this article. Clinical trials of coronary angiogenesis – issues, problems, consensus. An expert panel summary. Circulation 2000 102: e73- e86. Read this article. Factors controlling ocular angiogenesis. American Journal of Ophthalmology 1997;124:521-29. Read this article. Book Chapters: Angiogenesis-based medicine: principles and practice for disease prevention and intervention. In: Angiogenesis: Basic Science and Clinical Applications, Research Signpost, 2008. Molecular therapy for wounds: modalities for stimulating angiogenesis and granulation. In: The Wound Management Manual, McGraw Hill, NY, 2005. Tumor angiogenesis as a control point for early intervention and cancer prevention. In: Cancer Chemoprevention, Vol. 1: Promising Cancer Chemopreventive Agents, Humana Press, NJ, 2004. Angiogenesis and colorectal cancer: from the laboratory to the clinic. In: Colorectal Cancer, Humana Press, NJ, 2002 Angiogenesis therapies: concepts, clinical trials, and considerations for new drug development, in: The New Angiotherapy, Humana Press, NJ, 2002. Lessons to be learned from clinical trials of angiogenesis modulators in ischemic diseases, in: Angiogenesis in Health and Disease, M Dekker, NY, 1999. Clinical trials of angiogenesis-based therapies: overview and new guiding principles, in: Angiogenesis; Models, Modulators and Clinical Application, Plenum Press, NY, 1998.
Did you like this? If so, please bookmark it, RSS feed.